🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10178+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10178 recruiting trials

Phase 2RecruitingNCT07169279

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

🏥 QED Therapeutics, a BridgeBio company📍 13 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07076550

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

🏥 Alpha-9 Oncology USA Inc.📍 4 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07246941

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 3 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07161037

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

🏥 Vertex Pharmaceuticals Incorporated📍 35 sites📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07087054

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

🏥 Crinetics Pharmaceuticals Inc.📍 43 sites📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT06921317

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

👨‍⚕️ Peirong Lu, MD, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07295951

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07344012

Parental Project Amongst 93 Patients With Turner Syndrome

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06656351

B-FREE Chronic Babesiosis Study

🏥 60 Degrees Pharmaceuticals LLC📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07260175

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

👨‍⚕️ Salah Al-Batran, Prof. Dr., Frankfurter Institut für Klinische Krebsforschung IKF GmbH📍 8 sites📅 Started Nov 2025View details ↗
NARecruitingNCT07253493

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

👨‍⚕️ İlhan Karacan, Prof. Dr., stanbul Physical Medicine Rehabilitation Training and Research Hospital📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT06025734

Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

👨‍⚕️ Richard Adams, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07328841

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

👨‍⚕️ Ming-Yuan Chen, MD,PhD, Sun Yat-sen University📍 12 sites📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07175493

A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

🏥 Keymed Biosciences Co.Ltd📍 3 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07363460

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

👨‍⚕️ bicheng Liu, Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07296900

International Genetic Obesity Registry

🏥 University of Ulm📍 1 site📅 Started Nov 2025View details ↗
EARLY_Phase 1RecruitingNCT07348276

First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain

🏥 Invicro📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07448779

Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Nov 2025View details ↗
Phase 1Enrolling by InvitationNCT07218003

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

👨‍⚕️ Thomas Manley, MD, Rondo Therapeutics📍 7 sites📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT06887803

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

👨‍⚕️ Michael Lahn, Dr, iOnctura📍 7 sites📅 Started Nov 2025View details ↗
← PreviousPage 44 of 509Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →